PCSK9 (Bococizumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
FACS
Wirt: Humanized
Monoclonal
unconjugated
-
- Target Alle PCSK9 (Bococizumab Biosimilar) Produkte
- PCSK9 (Bococizumab Biosimilar)
- Reaktivität
- Human
-
Wirt
-
Humanized
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PCSK9 (Bococizumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Flow Cytometry (FACS)
- Verwendungszweck
- Anti-PCSK9 (Bococizumab biosimilar) mAb
- Produktmerkmale
- PF-04950615, RN-316, RN316
- Aufreinigung
- Purified from cell culture supernatant by affinity chromatography
- Güteklasse
- Research Grade
- Isotyp
- IgG2
-
-
- Applikationshinweise
- Flow Cyt 1:100
- Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Haltbarkeit
- 12 months
-
- Target
- PCSK9 (Bococizumab Biosimilar)
- Abstract
- PCSK9 (Bococizumab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Hintergrund
- FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9
- UniProt
- Q8NBP7
-
Sie sind hier:
